Abstract CT009: IMvoke010: A phase III, double-blind randomized trial of atezolizumab (atezo) after definitive local therapy vs placebo in patients (pts) with high-risk locally advanced (LA) squamous cell carcinoma of the head and neck (SCCHN)
Wong, Deborah J., Fayette, Jérôme, Teixeira, Maria, Prabhash, Kumar, Mesia, Ricard, Kawecki, Andrzej, Dechaphunkul, Arunee, Dinis, José, Guo, Ye, Masuda, Muneyuki, Hsieh, Ching-Yun, Ghi, Maria Grazia, de Melo Sette, Claudia Vaz, Jiang, Tao, Yan, Yibing, Kaul, Monika, Jagtiani, Ritika, Matheny, Christina, Cuchelkar, Vaikunth, Haddad, Robert
Published in Cancer research (Chicago, Ill.) (05.04.2024)
Published in Cancer research (Chicago, Ill.) (05.04.2024)
Get full text
Journal Article
Phase 1b study of cobimetinib plus atezolizumab in patients with advanced BRAF V600 wild-type melanoma progressing on prior anti-programmed death-1 therapy
Sandhu, Shahneen, Atkinson, Victoria, Cao, Maria González, Medina, Theresa, Rivas, Ainara Soria, Menzies, Alexander M, Caro, Ivor, Roberts, Louise, Song, Yuyao, Yan, Yibing, Guo, Yu, Xue, Cloris, Long, Georgina V
Published in European journal of cancer (1990) (01.01.2023)
Get full text
Published in European journal of cancer (1990) (01.01.2023)
Journal Article
Abstract PR03: CD8+ T-cell distribution and immunomodulator expression in BRAF-mutant melanoma affect the response to BRAF inhibitor and chemotherapy
Wongchenko, Matthew, Rabe, Christina, Sosman, Jeffrey, McArthur, Grant, Xiao, Yuanyuan, Gilbert, Houston, Andries, Luc, Kockx, Mark, Koeppen, Hartmut, Hegde, Priti, Amler, Lukas, Yan, Yibing, Ribas, Antoni
Published in Cancer research (Chicago, Ill.) (15.07.2015)
Published in Cancer research (Chicago, Ill.) (15.07.2015)
Get full text
Journal Article
Abstract 3395: BCR-Abl independent, Abl-TKI-therapy-resistant CML cells show enhanced sensitivity to GDC0941
Wagle, Marie, Wongchenko, Matthew, Lu, Shan, Guan, Yinghui, Wang, Yulei, Lackner, Mark, Hampton, Garret, Yan, Yibing
Published in Cancer research (Chicago, Ill.) (15.04.2013)
Published in Cancer research (Chicago, Ill.) (15.04.2013)
Get full text
Journal Article
A Cellular Striptease Act
Werb, Zena, Yan, Yibing
Published in Science (American Association for the Advancement of Science) (13.11.1998)
Published in Science (American Association for the Advancement of Science) (13.11.1998)
Get full text
Journal Article
Distinct gene expression, mutational profile and clinical outcomes of V600E and V600K/R BRAF-mutant metastatic melanoma (MM)
Pires Da Silva, Ines Esteves Domingues, Wang, Kevin Y. X., Wilmott, James S., Holst, Jeffrey, Park, John J, Quek, Camelia, Wongchenko, Matthew, Yan, Yibing, Mann, Graham J, Carlino, Matteo S., Kefford, Richard, Scolyer, Richard A., Yang, Jean, Long, Georgina V., Rizos, Helen, Menzies, Alexander M.
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article
Impact of MET expression on outcome in BRAF(V600E/K) advanced melanoma
Jubb, Adrian M, Ribas, Antoni, Sosman, Jeffrey A, McArthur, Grant A, Yan, Yibing, Rost, Sandra, Zhao, Sherry, Koeppen, Hartmut
Published in Histopathology (01.09.2013)
Published in Histopathology (01.09.2013)
Get full text
Journal Article
Abstract B03: Pharmacodynamic biomarker evaluation in phase I clinical trials of selective PI3K and PI3K/mTOR inhibitors
Nakanishi, Yoshito, Spoerke, Jill M., Derynck, Mika, Lauchle, Jennifer O., Koeppen, Hartmut, Fredrickson, Jill, Ware, Joseph, Hampton, Garret, Yan, Yibing, Lackner, Mark R.
Published in Molecular cancer therapeutics (01.07.2015)
Published in Molecular cancer therapeutics (01.07.2015)
Get full text
Journal Article
The association of BMI and outcomes in metastatic melanoma: A retrospective, multicohort analysis of patients treated with targeted therapy, immunotherapy, or chemotherapy
McQuade, Jennifer L., Daniel, Carrie R., Hess, Kenneth R., Mak, Carmen, Wang, Daniel Y., Rai, Rajat R., Park, John J., Haydu, Lauren E., Spencer, Christine, Wongchenko, Matthew, Lane, Stephen, Lee, Dung-Yang, Kaper, Mathilde, McKean, Meredith, Beckermann, Kathryn E, Rubinstein, Samuel M., Rooney, Isabelle, Musib, Luna, Budha, Nageshwar, Hsu, Jessie, Nowicki, Theodore S., Avila, Alexandre, Haas, Tomas, Puligandla, Maneka, Lee, Sandra, Fang, Shenying, Wargo, Jennifer A., Gershenwald, Jeffrey E, Lee, Jeffrey E., Hwu, Patrick, Chapman, Paul B., Sosman, Jeffrey A., Schadendorf, Dirk, Grob, Jean-Jacques, Flaherty, Keith T., Walker, Dana, Yan, Yibing, McKenna, Edward, Legos, Jeffrey J., Carlino, Matteo S., Ribas, Antoni, Kirkwood, John M., Long, Georgina V., Johnson, Douglas B., Menzies, Alexander M, Davies, Michael A.
Published in The lancet oncology (12.02.2018)
Published in The lancet oncology (12.02.2018)
Get full text
Journal Article
Abstract B62: Multiple genomic aberrations in BCR-ABL inhibitor-resistant cells lead to sensitivity towards MEK inhibition
Wagle, Marie-Claire, Wongchenko, Matthew J., Ramakrishnan, Vanitha, Hampton, Garret, Yan, Yibing
Published in Clinical cancer research (15.05.2012)
Published in Clinical cancer research (15.05.2012)
Get full text
Journal Article
Abstract 4374: Activation mechanism of oncogenic C-helix shifting mutations in BRAF, EGFR, and HER2
Foster, Scott, Whalen, Dan, Ozen, Aysegul, Wongchenko, Matt, Yin, JianPing, Yen, Ivana, Schaefer, Gabriele, Mayfield, John, Chmielecki, Juliann, Stephens, Phil, Albacker, Lee, Yan, Yibing, Song, Kyung, Hatzivassiliou, Georgia, Eigenbrot, Charles, Yu, Christine, Shaw, Andrey, Manning, Gerard, Skelton, Nicholas, Hymowitz, Sarah, Malek, Shiva
Published in Cancer research (Chicago, Ill.) (15.07.2016)
Published in Cancer research (Chicago, Ill.) (15.07.2016)
Get full text
Journal Article
Abstract 3231: Comprehensive profiling of actionab
Wang, Yulei, Bourgon, Richard, Lu, Shan, Yan, Yibing, Guan, Yinghui, Ryner, Lisa, Partel, Rajesh, Lackner, Mark, Amler, Lukas
Published in Cancer research (Chicago, Ill.) (15.04.2013)
Published in Cancer research (Chicago, Ill.) (15.04.2013)
Get full text
Journal Article
Adjuvant vemurafenib in resected, BRAF V600 mutation-positive melanoma (BRIM8): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial
Maio, Michele, Lewis, Karl, Demidov, Lev, Mandalà, Mario, Bondarenko, Igor, Ascierto, Paolo A, Herbert, Christopher, Mackiewicz, Andrzej, Rutkowski, Piotr, Guminski, Alexander, Goodman, Grant R, Simmons, Brian, Ye, Chenglin, Yan, Yibing, Schadendorf, Dirk
Published in The lancet oncology (01.04.2018)
Published in The lancet oncology (01.04.2018)
Get full text
Journal Article
Adjuvant vemurafenib in resected, BRAFV600 mutation-positive melanoma (BRIM8): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial
Maio, Michele, Lewis, Karl, Demidov, Lev, Bondarenko, Igor, Ascierto, Paolo A, Herbert, Christopher, Mackiewicz, Andrzej, Guminski, Alexander, Goodman, Grant R, Simmons, Brian, Ye, Chenglin, Cinat, Gabriela, Brown, Michael, Guminski, Alexander, Haydon, Andrew, Khattak, Adnan, McNeil, Catriona, Power, Jeremy, Roberts-Thomson, Rachel, Underhill, Craig, Berger, Thomas, Awada, Ahmad, Blockx, Nathalie, Buyse, Veronique, Mebis, Jeroen, Franke, Fábio André, Jobim de Azevedo, Sérgio, Silva Lazaretti, Nicolas, Mihalcioiu, Catalin, Petrella, Teresa, Song, Xinni, Wong, Ralph, Dabelic, Nina, Plestina, Stjepko, Vojnovic, Zeljko, Kocak, Ivo, Krajsova, Ivana, Kubala, Eugen, Melichar, Bohuslav, Dutriaux, Caroline, Joly, Pascal, Lacour, Jean-Philippe, Meyer, Nicolas, Mortier, Laurent, Fluck, Michael, Hassel, Jessica, Hauschild, Axel, Donnellan, Paul, McCaffrey, John, Power, Derek, Ariad, Samuel, Bar-Sela, Gil, Ron, Ilan, Schachter, Jacob, Berruti, Alfredo, Bianchi, Luca, Chiarion Sileni, Vanna, Cognetti, Francesco, Danielli, Riccardo, Di Giacomo, Anna Maria, Gianni, Luca, Goldhirsch, Aron, Guida, Michele, Maio, Michele, Mandalà, Mario, Marchetti, Paolo, Santoro, Armando, Kapiteijn, Ellen, Mackiewicz, Andrzej, Rutkowski, Piotr, Ferreira, Paula, Demidov, Lev, Gafton, Georgy, Makarova, Yulia, Jovanovic, Darjana, Kandolf Sekulovic, Lidija, Curiel Garcia, Maria Teresa, Majem Tarruella, Margarita, Marquez Rodas, Ivan, Puliats Rodriguez, Jose-M, Papworth, Karin, Bondarenko, Igor, Corrie, Pippa, Harries, Mark, Herbert, Christopher, Middleton, Mark, Patel, Poulam, Talbot, Toby, Agarwala, Sanjiv, Chapman, Paul, Conry, Robert, Doolittle, Gary, Gangadhar, Tara, Hallmeyer, Sigrun, Kass, Frederic, Lewis, Karl, Salama, April, Sikic, Branimir, Spigel, David, Whitman, Eric
Published in The lancet oncology (01.04.2018)
Published in The lancet oncology (01.04.2018)
Get full text
Journal Article
Cobimetinib combined with vemurafenib in advanced BRAF V600 -mutant melanoma (coBRIM): updated efficacy results from a randomised, double-blind, phase 3 trial
Ascierto, Paolo A., Mcarthur, Grant A, Dréno, Brigitte, Atkinson, Victoria A, Liszkay, Gabrielle, Di Giacomo, Anna Maria, Mandalà, Mario, Demidov, Lev, Stroyakovskiy, Daniil, Thomas, Luc, de La Cruz-Merino, Luis, Dutriaux, Caroline, Garbe, Claus, Yan, Yibing, Wongchenko, Matthew, Chang, Ilsung, Hsu, Jessie J, Koralek, Daniel O, Rooney, Isabelle, Ribas, Antoni A, Larkin, James J
Published in The lancet oncology (2016)
Get full text
Published in The lancet oncology (2016)
Journal Article
Abstract 915: Expanded biomarker results from a phase I dose escalation study of GDC-0032, a beta isoform-sparing PI3K inhibitor
Wilson, Timothy R., Savage, Heidi, O'Brien, Carol, Sanabria, Sandra, Lin, Ray S., Wagle, Marie-Claire, Yan, Yibing, Lackner, Mark R., Parmar, Hema, Hsu, Jerry Y., Juric, Dejan, Krop, Ian E., Ramanathan, Ramesh K., Hoff, Daniel D. Von, Baselga, Jose
Published in Cancer research (Chicago, Ill.) (01.10.2014)
Published in Cancer research (Chicago, Ill.) (01.10.2014)
Get full text
Journal Article
Abstract 4819: Evaluation of PTEN status in circulating tumor cells (CTCs) and matched tumor tissue from castrate-resistant prostate cancer (CRPC) patients
Punnoose, Elizabeth, Tucker, Eric, Szafer-Glusman, Edith, Zhu, Jin, Marrinucci, Dena, Louw, Jessica, Lee, Florence, Kitchen, Mikel, Bales, Natalee, Amler, Lukas, Koeppen, Hartmut, Patel, Premal, Yan, Yibing, Riisnaes, Ruth, Attard, Gerhardt, Bono, Johann de
Published in Cancer research (Chicago, Ill.) (01.10.2014)
Published in Cancer research (Chicago, Ill.) (01.10.2014)
Get full text
Journal Article
Impact of MET expression on outcome in BRAF V600E/K advanced melanoma
Jubb, Adrian M, Ribas, Antoni, Sosman, Jeffrey A, McArthur, Grant A, Yan, Yibing, Rost, Sandra, Zhao, Sherry, Koeppen, Hartmut
Published in Histopathology (01.09.2013)
Published in Histopathology (01.09.2013)
Get full text
Journal Article